Sagimet Biosciences Inc. Cash Flow Statement

Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -27.88M
Share-based Compensation 1.88M4.99M5.29M
Gains from Investment Securities -0.00M3.75M0.15M
Non-cash Items 2.14M
Cash from Operations -24.49M-23.77M-42.44M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.21M0.04M1.25M
Change in Working Capital
Change in Accured Expenses 2.92M0.12M-0.91M
Other Working Capital Changes -1.44M0.01M-0.14M
Investing Activities
Change in Acquisitions & Divestments 9.44M32.20M46.40M
Cash from Investing Activities -32.01M12.58M-61.68M
Financing Activities
Other financing activities 0.09M3.52M1.04M
Cash from Financing Activities -0.07M86.17M104.82M
Additional items
Change in Cash -56.57M74.98M0.70M
Free Cash Flow -24.49M-23.77M-42.44M
Net Cash Flow -56.57M74.98M0.70M